Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank71
3Y CAGR-82.2%
5Y CAGR-73.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-82.2%/yr
Annual compound
5Y CAGR
-73.9%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.15% |
| 2024 | 58.92% |
| 2023 | -53.99% |
| 2022 | 26.59% |
| 2021 | -512.38% |
| 2020 | 123.54% |
| 2019 | -17.45% |
| 2018 | -67.53% |
| 2017 | 5.62% |
| 2016 | -64.47% |